Knowledge of, and beliefs about, access to screening facilities and cervical cancer screening behaviors among low-income women in New Jersey
Silvera SAN, Bandera EV, Jones BA, Kaplan AM, Demisse K. Knowledge of, and beliefs about, access to screening facilities and cervical cancer screening behaviors among low-income women in New Jersey. Cancer Causes & Control 2019, 31: 43-49. PMID: 31720918, PMCID: PMC9083372, DOI: 10.1007/s10552-019-01244-5.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedCross-Sectional StudiesEarly Detection of CancerEthnicityFemaleHealth Knowledge, Attitudes, PracticeHealth Services AccessibilityHealth Status DisparitiesHealthcare DisparitiesHumansLogistic ModelsMass ScreeningMiddle AgedMultivariate AnalysisNew JerseyPapanicolaou TestPovertyRacial GroupsRiskUterine Cervical NeoplasmsVaginal SmearsYoung AdultConceptsLow-income womenCervical cancerCancer outcomesCervical cancer outcomesMultivariate logistic regressionCross-sectional studyPap testingPap testCancer screeningInsurance statusCancer testsPrevention strategiesEthnic disparitiesLogistic regressionSocioeconomic differencesCancerWomenAffordable screeningScreening facilityScreeningOutcomesRisk awarenessNew JerseyYearsSerious adverse events in African–American cancer patients with sickle cell trait and inherited haemoglobinopathies in a SEER-Medicare claims cohort
Hoag JR, Andemariam B, Wang X, Gregorio DI, Jones BA, Sporn J, Salner AL, Swede H. Serious adverse events in African–American cancer patients with sickle cell trait and inherited haemoglobinopathies in a SEER-Medicare claims cohort. British Journal Of Cancer 2019, 120: 861-863. PMID: 30890774, PMCID: PMC6474269, DOI: 10.1038/s41416-019-0416-7.Peer-Reviewed Original ResearchConceptsSickle cell traitAfrican American cancer patientsSerious adverse eventsAdverse eventsNon-Hispanic whitesCancer patientsRelative riskCell traitEmergency department visitsSEER-Medicare databaseDepartment visitsPrognostic impactAA patientsCancer outcomesWorse outcomesProstate cancerCohort analysisPatientsClaims cohortMagnitude of effectCancer typesAA populationHaemoglobinopathiesOutcomesRisk